Manufacturer record
Unimark Healthcare Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Unimark Healthcare Ltd (Uttarakhand) were declared Not of Standard Quality between April 2021 and May 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Unimark Healthcare Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Fluconazole Tablets IP (150 mg).. | UGT233 38Mfg 2023-03 · Exp 2025-02 | The sample received does not conform to the I.P.2022 standard with respect to the test for Related substances.Related substances | CDTL MumbaiCDSCO lab | May 2024 |
| Silodosin 4 mg and Dutasteride 0.5 mg Tablets | UGT22309Mfg 2022-03 · Exp 2024-02 | DisintegrationDisintegration | CDL KolkataCDSCO lab | Oct 2022 |
| MISOPROSTOL Tablets I.P. 200 mcg | UHT20096Mfg 2020-07 · Exp 2022-06 | AssayAssay | CDL KolkataCDSCO lab | Apr 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.